Kailash Bhatia, MD
University College London London, United Kingdom
Barbara Kelly Changizi, MD
Brigham and Women’ s Hospital, Harvard Medical School Boston, Massachusetts
David Coughlin, MD
University of California, San Diego San Diego, California
Kailash Bhatia is a professor in the Department of Clinical and Movement Neuroscience at the Institute of Neurology, University College London and an honorary consultant neurologist at the National Hospital for Neurology and Neurosurgery. His primary research interest is in movement disorders, merging clinical, electrophysiological and genetic methods to study the pathophysiology of Parkinson’ s disease. He has authored over 520 publications and is the founding and current editor of the journal Movement Disorders Clinical Practice. Dr. Bhatia has extensive teaching experience and has been invited to speak at multiple conferences, including the International Congress of Parkinson’ s Disease and Movement Disorders annual meeting.
Barbara Kelly Changizi is the director of Clinical Operations of the Movement Disorders Division and co-director of the Movement Disorders Fellowship Program at Brigham and Women’ s Hospital in Boston. She is an expert in Parkinson’ s disease, particularly advanced disease requiring deep brain stimulation. She is also an expert in parkinsonian disorders and is co-director of the Multiple System Atrophy Mission Center of Excellence at Brigham and Women’ s Hospital. Her research interests are in public health, particularly the affordability of prescription drugs for neurodegenerative disease, and the rising costs of hospital systems. She will obtain her master’ s degree from the Harvard Chan School of Public Health in 2027.
David Coughlin is a neurologist and movement disorders specialist. He is an associate clinical professor in the Department of Neurosciences, where he trains medical students, residents and fellows at the University of California, San Diego School of Medicine. Dr. Coughlin completed his neurology residency and a fellowship in movement disorders at the University of Pennsylvania; he also holds a master’ s degree in translational research from the University of Pennsylvania. His research focuses on neuropathology and biomarker signatures in movement disorders and neurodegenerative diseases. His work has been published in several peer-reviewed journals.
Fall 2026 17